Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL299 Target Snapshot

Protein kinase C alpha type · SINGLE PROTEIN · Homo sapiens

4,039Compounds
828Assays
9Approved Drugs
3,787.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P17252. Use UniProt P17252 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P17252 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein kinase C alpha type as ChEMBL target CHEMBL299, mapped to UniProt P17252. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein kinase C alpha type
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL299
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P17252
Protein kinase C alpha type
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein kinase C alpha type is the right protein anchor across sources, using UniProt P17252 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein kinase C alpha type
UniProt AccessionP17252
Component TypeProtein
Sequence Length672 aa

Protein kinase C alpha type

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein kinase C alpha type, mapped to UniProt P17252. Sequence length is 672 aa.

Mapped IDP17252
Review nameProtein kinase C alpha type
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

9
Approved
8
Phase III
14
Phase II
6
Phase I
Assay Mix

Activity Type Distribution

IC502,035.0
KI1,462.0
EC505.0
KD285.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3892099 9.89 IC50 0.13 Preclinical
CHEMBL3893533 9.89 IC50 0.13 Preclinical
CHEMBL3895998 9.89 IC50 0.13 Preclinical
CHEMBL3920517 9.89 IC50 0.13 Preclinical
CHEMBL3932204 9.89 IC50 0.13 Preclinical
CHEMBL3943147 9.89 IC50 0.13 Preclinical
CHEMBL3951893 9.89 IC50 0.13 Preclinical
CHEMBL3957715 9.89 IC50 0.13 Preclinical
CHEMBL3958761 9.89 IC50 0.13 Preclinical
CHEMBL3958917 9.89 IC50 0.13 Preclinical
Distribution

pChEMBL Value Distribution

125
5.0
142
5.5
194
6.0
146
6.5
178
7.0
183
7.5
111
8.0
69
8.5
68
9.0
53
9.5
pChEMBL
Approved Drugs

Approved Drugs

PACRITINIB
CHEMBL2035187
Approved 2022
GILTERITINIB
CHEMBL3301622
Approved 2018
ABEMACICLIB
CHEMBL3301610
Approved 2017
MIDOSTAURIN
CHEMBL608533
Approved 2017
Assay Landscape

Assay Landscape

828
Total Assays
1,210
Tested Compounds
3
Assay Types
Binding — 821 assays, 1,210 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 689 1,007 6.9
cell-based format 64 42 6.0
assay format 54 108 6.7
subcellular format 12 27 6.0
cell membrane format 2 26 7.3
Functional — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 0
ADME — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine